These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10768162)

  • 1. [Tiagabine in drug-resistant epilepsy in children: preliminary study].
    Wendorff J; Popielarczyk M; Zubiel M; Sokołowska D
    Neurol Neurochir Pol; 2000; 34 Suppl 1():221-4. PubMed ID: 10768162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the effectiveness of add-on therapy with tiagabine and evaluation of cognitive functions after application of this therapy in patients with drug-resistant focal epilepsy - an observational study (GABI-EPI)].
    Halczuk I; Lipa A; Mitosek-Szewczyk K; Sobolewski P; Stelmasiak Z; Kaczyński K
    Wiad Lek; 2015; 68(4 Pt 2):680-9. PubMed ID: 27162312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiagabine (gabitril) experience in children.
    Pellock JM
    Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determinants of tiagabine (TGB) efficacy and safety. A Polish multicenter study of 1307 patients with focal epilepsy].
    Kozik A; Krause M
    Neurol Neurochir Pol; 2003; 37(3):537-46. PubMed ID: 14593750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group.
    Sachdeo RC; Leroy RF; Krauss GL; Drake ME; Green PM; Leppik IE; Shu VS; Ringham GL; Sommerville KW
    Arch Neurol; 1997 May; 54(5):595-601. PubMed ID: 9152116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiagabine: new preparation. Refractory partial epilepsy: another alternative.
    Prescrire Int; 1998 Aug; 7(36):99-101. PubMed ID: 10342943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Open study with tiagabine in partial epilepsy].
    Arroyo S
    Rev Neurol; 2000 Oct 16-31; 31(8):728-32. PubMed ID: 11082879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An open study of tiagabine in partial epilepsy].
    Arroyo S; Salas-Puig J;
    Rev Neurol; 2001 Jun 1-15; 32(11):1041-6. PubMed ID: 11562825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
    Chmielewska B; Stelmasiak Z
    Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC; Noble S
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tiagabine on spasticity in children with intractable epilepsy: a pilot study.
    Holden KR; Titus MO
    Pediatr Neurol; 1999 Oct; 21(4):728-30. PubMed ID: 10580885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine.
    Shinnar S
    Semin Pediatr Neurol; 1997 Mar; 4(1):24-33. PubMed ID: 9097364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tiagabine in the treatment of intractable epilepsy of childhood with multifocal independent spikes: a case report.
    Akman CI; Schubert R
    Clin Electroencephalogr; 2000 Oct; 31(4):207-10. PubMed ID: 11056844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tiagabine--own experience in the refractory epilepsy treatment].
    Błaszczyk B
    Wiad Lek; 2013; 66(2 Pt 2):175-9. PubMed ID: 25775813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy.
    Arroyo S; Boothman BR; Brodie MJ; Duncan JS; Duncan R; Nieto M; Calandre EP; Forcadas I; Crawford PM
    Seizure; 2005 Mar; 14(2):81-4. PubMed ID: 15694559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of tiagabine efficacy in different groups of patients with epilepsy].
    Jedrzejczak J
    Neurol Neurochir Pol; 2000; 34 Suppl 7():9-16. PubMed ID: 11253491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety of tiagabine.
    Kälviäinen R
    Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of tiagabine: a prospective open-label study.
    Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
    Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician.
    Schmidt D; Gram L; Brodie M; Krämer G; Perucca E; Kälviäinen R; Elger CE
    Epilepsy Res; 2000 Oct; 41(3):245-51. PubMed ID: 10962215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.